Highlights the need for further studies on the net clinical benefit of thrombolysis in high-risk subgroups due to the risk of stroke.
Stroke remains a rare but catastrophic complication of thrombolysis. Additional studies should assess the net clinical benefit of thrombolysis in high-risk subgroups, particularly the elderly and patients with prior cerebrovascular events.
Gore et al. (Wed,) studied this question.